We’re back with another exciting episode of “Inside Scailyte,” where we delve into the incredible journeys and talents of our team members. In this episode, get ready to meet Filipa Teixeira, our Business Development Associate at Scailyte.
Continue reading
Scailyte’s powerful single-cell AI platform, ScaiVision, has played a pivotal role in a groundbreaking move in the field of endometriosis. Hera Biotech is set to acquire and bring to the patients Scailyte’s endometriosis diagnostic assets, marking a significant milestone in non-surgical diagnosis of endometriosis.
Continue reading
In our inaugural episode, we are honored to introduce you to Diana Stoycheva, our Principal Expert Scientist. Diana’s expertise in immunology and immunooncology which could be considered instrumental in applying our unique proprietary AI approach to revolutionize precision medicine.
Continue reading
Happy Holidays 2023
As the holiday season approaches, we want to extend our warmest wishes to all our colleagues, clients, and friends around the world.
Whether you’re celebrating Christmas, Asara B’Tevet, Kwanzaa, Gita Mahotsav, or any other end of year holiday, may this season be filled with joy, love, and togetherness.
At Scailyte, we embrace the rich tapestry of cultures and beliefs that make our global community so vibrant. Let’s come together to appreciate our precious diversity, our shared values of innovation and collaboration in the quest of knowledge that matters to patients.
Here’s to a joyful holiday season and a New Year filled with health, prosperity, and continued success. Happy Holidays from all of us at Scailyte!
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...
In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...
Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...
Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...
We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...
Scailyte's powerful single-cell AI platform, ScaiVision, has played a pivotal role in a groundbreaki...
In our inaugural episode, we are honored to introduce you to Diana Stoycheva, our Principal Expert S...
We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...
In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...
Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...
Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...
We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...
Scailyte's powerful single-cell AI platform, ScaiVision, has played a pivotal role in a groundbreaki...
In our inaugural episode, we are honored to introduce you to Diana Stoycheva, our Principal Expert S...
We are thrilled to announce the extension of our Series A funding, bringing the total raised amount to USD 8 million.
Continue reading
Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell analysis. In this edition, Sukalp Muzumdar, Senior Data Scientist at Scailyte, delves into the transformative role of Variational Autoencoders (VAEs) in biology.
Continue reading
We’re excited to share that our Senior Vice President of Corporate & Technology Development, Corinne Solier, will be pitching at the “Pitch-nic Expo” event hosted at the Novartis Campus.
Continue reading
Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in Berlin.
Continue reading
We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI landscape.
Continue reading
Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in London, UK, on November 9-10.
Continue reading
